ICD-10-PCS FY2026 code changes

ICD-10-PCS update effective October 1, 2025: 156 new codes, 27 deleted, 0 revised titles. Compared with FY2025 (April 1, 2025). Source: the official CMS order files.

Other ICD-10-PCS releases: FY2027, FY2026 (April 1, 2026), FY2025 (April 1, 2025), FY2025, FY2024 (April 1, 2024), FY2024, FY2023 (April 1, 2023), FY2023, FY2022 (April 1, 2022), FY2022, FY2021 (January 1, 2021), FY2021, FY2020 (August 1, 2020), FY2020, FY2019, FY2018, FY2017.

Also in this release: ICD-10-CM changes.

New codes (156)

• 00H033J Insertion of Infusion Device into Brain, Temporary, Percutaneous Approach
• 00P207Z Removal of Autologous Tissue Substitute from Dura Mater, Open Approach
• 00P20JZ Removal of Synthetic Substitute from Dura Mater, Open Approach
• 00P20KZ Removal of Nonautologous Tissue Substitute from Dura Mater, Open Approach
• 00PT07Z Removal of Autologous Tissue Substitute from Spinal Meninges, Open Approach
• 00PT0JZ Removal of Synthetic Substitute from Spinal Meninges, Open Approach
• 00PT0KZ Removal of Nonautologous Tissue Substitute from Spinal Meninges, Open Approach
• 00W207Z Revision of Autologous Tissue Substitute in Dura Mater, Open Approach
• 00W20JZ Revision of Synthetic Substitute in Dura Mater, Open Approach
• 00W20KZ Revision of Nonautologous Tissue Substitute in Dura Mater, Open Approach
• 00WT07Z Revision of Autologous Tissue Substitute in Spinal Meninges, Open Approach
• 00WT0JZ Revision of Synthetic Substitute in Spinal Meninges, Open Approach
• 00WT0KZ Revision of Nonautologous Tissue Substitute in Spinal Meninges, Open Approach
• 02UW3LZ Supplement Thoracic Aorta, Descending with Intraluminal Device, Endovascular Anchors, Percutaneous Approach
• 031209Y Bypass Innominate Artery to Upper Artery with Autologous Venous Tissue, Open Approach
• 03120AY Bypass Innominate Artery to Upper Artery with Autologous Arterial Tissue, Open Approach
• 03120JY Bypass Innominate Artery to Upper Artery with Synthetic Substitute, Open Approach
• 03120KY Bypass Innominate Artery to Upper Artery with Nonautologous Tissue Substitute, Open Approach
• 03120ZY Bypass Innominate Artery to Upper Artery, Open Approach
• 04U03LZ Supplement Abdominal Aorta with Intraluminal Device, Endovascular Anchors, Percutaneous Approach
• 09XK0Z1 Transfer Nasal Mucosa and Soft Tissue to Frontal Bone, Open Approach
• 09XK0Z2 Transfer Nasal Mucosa and Soft Tissue to Ethmoid Bone, Open Approach
• 09XK0Z3 Transfer Nasal Mucosa and Soft Tissue to Sphenoid Bone, Open Approach
• 09XK0Z4 Transfer Nasal Mucosa and Soft Tissue to Occipital Bone, Open Approach
• 09XL0Z1 Transfer Nasal Turbinate to Frontal Bone, Open Approach
• 09XL0Z2 Transfer Nasal Turbinate to Ethmoid Bone, Open Approach
• 09XL0Z3 Transfer Nasal Turbinate to Sphenoid Bone, Open Approach
• 09XL0Z4 Transfer Nasal Turbinate to Occipital Bone, Open Approach
• 09XM0Z1 Transfer Nasal Septum to Frontal Bone, Open Approach
• 09XM0Z2 Transfer Nasal Septum to Ethmoid Bone, Open Approach
• 09XM0Z3 Transfer Nasal Septum to Sphenoid Bone, Open Approach
• 09XM0Z4 Transfer Nasal Septum to Occipital Bone, Open Approach
• 0C1S0E4 Bypass Larynx to Cutaneous with Endotracheal Airway, Open Approach
• 0C1S0F4 Bypass Larynx to Cutaneous with Tracheostomy Device, Open Approach
• 0C1S0Z4 Bypass Larynx to Cutaneous, Open Approach
• 0C1S3E4 Bypass Larynx to Cutaneous with Endotracheal Airway, Percutaneous Approach
• 0C1S3F4 Bypass Larynx to Cutaneous with Tracheostomy Device, Percutaneous Approach
• 0C1S3Z4 Bypass Larynx to Cutaneous, Percutaneous Approach
• 0F198D3 Bypass Common Bile Duct to Duodenum with Intraluminal Device, Via Natural or Artificial Opening Endoscopic
• 0F198Z3 Bypass Common Bile Duct to Duodenum, Via Natural or Artificial Opening Endoscopic
• 0RRJ008 Replacement of Right Shoulder Joint with Reverse Ball and Socket Synthetic Substitute, Subscapularis-sparing Technique, Open Approach
• 0RRJ0J8 Replacement of Right Shoulder Joint with Synthetic Substitute, Subscapularis-sparing Technique, Open Approach
• 0RRK008 Replacement of Left Shoulder Joint with Reverse Ball and Socket Synthetic Substitute, Subscapularis-sparing Technique, Open Approach
• 0RRK0J8 Replacement of Left Shoulder Joint with Synthetic Substitute, Subscapularis-sparing Technique, Open Approach
• 0SRC07D Replacement of Right Knee Joint with Autologous Tissue Substitute, Medial Meniscus, Open Approach
• 0SRC07E Replacement of Right Knee Joint with Autologous Tissue Substitute, Lateral Meniscus, Open Approach
• 0SRC0KD Replacement of Right Knee Joint with Nonautologous Tissue Substitute, Medial Meniscus, Open Approach
• 0SRC0KE Replacement of Right Knee Joint with Nonautologous Tissue Substitute, Lateral Meniscus, Open Approach
• 0SRD07D Replacement of Left Knee Joint with Autologous Tissue Substitute, Medial Meniscus, Open Approach
• 0SRD07E Replacement of Left Knee Joint with Autologous Tissue Substitute, Lateral Meniscus, Open Approach
• 0SRD0KD Replacement of Left Knee Joint with Nonautologous Tissue Substitute, Medial Meniscus, Open Approach
• 0SRD0KE Replacement of Left Knee Joint with Nonautologous Tissue Substitute, Lateral Meniscus, Open Approach
• 5A05A6M Intraoperative Cerebral Embolic Filtration, Single Capture Filter
• 5A05A6N Intraoperative Cerebral Embolic Filtration, Dual Capture Filter
• 5A05A6P Intraoperative Cerebral Embolic Filtration, Single Deflection Filter
• 5A05A6Q Intraoperative Cerebral Embolic Filtration, Extracorporeal Flow Reversal Circuit
• 6A4T00A Hypothermia of Urinary System using Donor Organ Protective Thermal Insulation, Single, Intraoperative
• 8E0ZXGP External Confocal Microscopy, Intraoperative Specimen Analysis
• F08D5AZ Wound Management Treatment of Integumentary System - Head and Neck using Negative Pressure Therapy
• F08F5AZ Wound Management Treatment of Integumentary System - Upper Back / Upper Extremity using Negative Pressure Therapy
• F08G5AZ Wound Management Treatment of Integumentary System - Lower Back / Lower Extremity using Negative Pressure Therapy
• F08H5AZ Wound Management Treatment of Integumentary System - Whole Body using Negative Pressure Therapy
• F08J5AZ Wound Management Treatment of Musculoskeletal System - Head and Neck using Negative Pressure Therapy
• F08K5AZ Wound Management Treatment of Musculoskeletal System - Upper Back / Upper Extremity using Negative Pressure Therapy
• F08L5AZ Wound Management Treatment of Musculoskeletal System - Lower Back / Lower Extremity using Negative Pressure Therapy
• F08M5AZ Wound Management Treatment of Musculoskeletal System - Whole Body using Negative Pressure Therapy
• X05233B Destruction of Thoracic Sympathetic Nerve, Cardiac Plexus using Radiofrequency Ablation, Percutaneous Approach, New Technology Group 11
• X053X4B Destruction of Brain using Focused Ultrasound Therapy, External Approach, New Technology Group 11
• X27339B Dilation of Right Pulmonary Artery with Expandable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X27439B Dilation of Left Pulmonary Artery with Expandable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X27535B Dilation of Right Subclavian Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X27635B Dilation of Left Subclavian Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X27735B Dilation of Right Axillary Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X27835B Dilation of Left Axillary Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X27935B Dilation of Right Brachial Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X27A35B Dilation of Left Brachial Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X27B35B Dilation of Right Basilic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X27C35B Dilation of Left Basilic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X27D35B Dilation of Right Cephalic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X27E35B Dilation of Left Cephalic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X27W39B Dilation of Thoracic Aorta, Descending with Expandable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X27X39B Dilation of Thoracic Aorta, Ascending/Arch with Expandable Intraluminal Device, Percutaneous Approach, New Technology Group 11
• X28F3WB Division of Aortic Valve using Leaflet Laceration, Radiofrequency Energy, Percutaneous Approach, New Technology Group 11
• X2AH34B Right Common Carotid Artery Cerebral Embolic Filtration, Single Integrated Distal Filter, Percutaneous Approach, New Technology Group 11
• X2AJ34B Left Common Carotid Artery Cerebral Embolic Filtration, Single Integrated Distal Filter, Percutaneous Approach, New Technology Group 11
• X2AK34B Right Internal Carotid Artery Cerebral Embolic Filtration, Single Integrated Distal Filter, Percutaneous Approach, New Technology Group 11
• X2AL34B Left Internal Carotid Artery Cerebral Embolic Filtration, Single Integrated Distal Filter, Percutaneous Approach, New Technology Group 11
• X2H03BB Insertion of Volume Sensor Management Device into Inferior Vena Cava, Percutaneous Approach, New Technology Group 11
• X2H13XB Insertion of Temporary Phrenic Nerve/Diaphragm Stimulation Electrodes into Superior Vena Cava, Percutaneous Approach, New Technology Group 11
• X2HN37B Insertion of Endocardiac Pacing Electrode into Left Ventricle, Percutaneous Approach, New Technology Group 11
• X2HP38B Insertion of Temporary Intraluminal Device into Right Anterior Tibial Artery, Percutaneous Approach, New Technology Group 11
• X2HQ38B Insertion of Temporary Intraluminal Device into Left Anterior Tibial Artery, Percutaneous Approach, New Technology Group 11
• X2HR38B Insertion of Temporary Intraluminal Device into Right Posterior Tibial Artery, Percutaneous Approach, New Technology Group 11
• X2HS38B Insertion of Temporary Intraluminal Device into Left Posterior Tibial Artery, Percutaneous Approach, New Technology Group 11
• X2HT38B Insertion of Temporary Intraluminal Device into Right Peroneal Artery, Percutaneous Approach, New Technology Group 11
• X2HU38B Insertion of Temporary Intraluminal Device into Left Peroneal Artery, Percutaneous Approach, New Technology Group 11
• X2VY06B Restriction of Thoracic Aortic Arch and Descending Thoracic Aorta using Uncovered Intraluminal Device with Support Cuff, Open Approach, New Technology Group 11
• XDJ07LB Inspection of Upper Intestinal Tract using Ingestible Capsule with Light Absorption Sensor, Via Natural or Artificial Opening, New Technology Group 11
• XHH80HB Insertion of Ultrasound Transmitter and Battery for Endocardiac Pacing Electrode into Chest Subcutaneous Tissue and Fascia, Open Approach, New Technology Group 11
• XNH60HB Insertion of Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device into Right Pelvic Bone, Open Approach, New Technology Group 11
• XNH63HB Insertion of Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device into Right Pelvic Bone, Percutaneous Approach, New Technology Group 11
• XNH70HB Insertion of Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device into Left Pelvic Bone, Open Approach, New Technology Group 11
• XNH73HB Insertion of Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device into Left Pelvic Bone, Percutaneous Approach, New Technology Group 11
• XNSN0HB Reposition Right Pelvic Bone with Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Open Approach, New Technology Group 11
• XNSN3HB Reposition Right Pelvic Bone with Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Percutaneous Approach, New Technology Group 11
• XNSP0HB Reposition Left Pelvic Bone with Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Open Approach, New Technology Group 11
• XNSP3HB Reposition Left Pelvic Bone with Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Percutaneous Approach, New Technology Group 11
• XRG10RB Fusion of Cervical Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 11
• XRG13RB Fusion of Cervical Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 11
• XRG14RB Fusion of Cervical Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 11
• XRG20RB Fusion of 2 or more Cervical Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 11
• XRG23RB Fusion of 2 or more Cervical Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 11
• XRG24RB Fusion of 2 or more Cervical Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 11
• XRG40RB Fusion of Cervicothoracic Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 11
• XRG43RB Fusion of Cervicothoracic Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 11
• XRG44RB Fusion of Cervicothoracic Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 11
• XRGE0HB Fusion of Right Sacroiliac Joint using Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Open Approach, New Technology Group 11
• XRGE3HB Fusion of Right Sacroiliac Joint using Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Percutaneous Approach, New Technology Group 11
• XRGF0HB Fusion of Left Sacroiliac Joint using Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Open Approach, New Technology Group 11
• XRGF3HB Fusion of Left Sacroiliac Joint using Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Percutaneous Approach, New Technology Group 11
• XRH10GB Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Cervical Vertebral Joint, Open Approach, New Technology Group 11
• XRH13GB Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Cervical Vertebral Joint, Percutaneous Approach, New Technology Group 11
• XRH14GB Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Cervical Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 11
• XRH20GB Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Open Approach, New Technology Group 11
• XRH23GB Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Percutaneous Approach, New Technology Group 11
• XRH24GB Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 11
• XRH40GB Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Open Approach, New Technology Group 11
• XRH43GB Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Percutaneous Approach, New Technology Group 11
• XRH44GB Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 11
• XRH60GB Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Thoracic Vertebral Joint, Open Approach, New Technology Group 11
• XRH63GB Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Approach, New Technology Group 11
• XRH64GB Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 11
• XW013TB Introduction of Rozanolixizumab-noli Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 11
• XW033FB Introduction of Valoctocogene Roxaparvovec-rvox into Peripheral Vein, Percutaneous Approach, New Technology Group 11
• XW033PB Introduction of Aztreonam-avibactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 11
• XW033QB Introduction of Iloprost into Peripheral Vein, Percutaneous Approach, New Technology Group 11
• XW033RB Introduction of Letetresgene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 11
• XW033WB Introduction of Fosfomycin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 11
• XW043FB Introduction of Valoctocogene Roxaparvovec-rvox into Central Vein, Percutaneous Approach, New Technology Group 11
• XW043PB Introduction of Aztreonam-avibactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 11
• XW043QB Introduction of Iloprost into Central Vein, Percutaneous Approach, New Technology Group 11
• XW043RB Introduction of Letetresgene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 11
• XW043WB Introduction of Fosfomycin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 11
• XW0DXVB Introduction of Xanomeline and Trospium Chloride into Mouth and Pharynx, External Approach, New Technology Group 11
• XW0U0XB Introduction of Peptide Enhanced Bone Void Filler into Joints, Open Approach, New Technology Group 11
• XW0U3XB Introduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Approach, New Technology Group 11
• XW0U4XB Introduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Endoscopic Approach, New Technology Group 11
• XW133SB Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11
• XW133YB Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, New Technology Group 11
• XW143SB Transfusion of Mozafancogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 11
• XW143YB Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Central Vein, Percutaneous Approach, New Technology Group 11
• XX2KXDB Monitoring of Interstitial Glucose, Wearable Sensor, External Approach, New Technology Group 11
• XXA539B Circulatory Filtration, Ticagrelor, Percutaneous Approach, New Technology Group 11
• XXE5XBB Measurement of Infection and Immune Response, Gene Expression Testing System, New Technology Group 11
• XXEZXAB Measurement of Macronutrient Content, Computer-aided Assessment for Nutrition Management, New Technology Group 11
• XXEZXCB Measurement of Infection, Computer-aided Triage and Notification, New Technology Group 11

Deleted codes (27)

• X2A5312 Cerebral Embolic Filtration, Dual Filter in Innominate Artery and Left Common Carotid Artery, Percutaneous Approach, New Technology Group 2
• X2A6325 Cerebral Embolic Filtration, Single Deflection Filter in Aortic Arch, Percutaneous Approach, New Technology Group 5
• X2AH336 Cerebral Embolic Filtration, Extracorporeal Flow Reversal Circuit from Right Common Carotid Artery, Percutaneous Approach, New Technology Group 6
• X2AJ336 Cerebral Embolic Filtration, Extracorporeal Flow Reversal Circuit from Left Common Carotid Artery, Percutaneous Approach, New Technology Group 6
• XW03306 Introduction of Brexanolone into Peripheral Vein, Percutaneous Approach, New Technology Group 6
• XW03326 Introduction of Nerinitide into Peripheral Vein, Percutaneous Approach, New Technology Group 6
• XW03336 Introduction of Durvalumab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 6
• XW03366 Introduction of Lefamulin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6
• XW033A6 Introduction of Cefiderocol Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6
• XW033B6 Introduction of Omadacycline Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6
• XW033C6 Introduction of Eculizumab into Peripheral Vein, Percutaneous Approach, New Technology Group 6
• XW033D6 Introduction of Atezolizumab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 6
• XW033E6 Introduction of Etesevimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 6
• XW033F6 Introduction of Bamlanivimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 6
• XW04306 Introduction of Brexanolone into Central Vein, Percutaneous Approach, New Technology Group 6
• XW04326 Introduction of Nerinitide into Central Vein, Percutaneous Approach, New Technology Group 6
• XW04336 Introduction of Durvalumab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 6
• XW04366 Introduction of Lefamulin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6
• XW043A6 Introduction of Cefiderocol Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6
• XW043B6 Introduction of Omadacycline Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6
• XW043C6 Introduction of Eculizumab into Central Vein, Percutaneous Approach, New Technology Group 6
• XW043D6 Introduction of Atezolizumab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 6
• XW043E6 Introduction of Etesevimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 6
• XW043F6 Introduction of Bamlanivimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 6
• XW0DX66 Introduction of Lefamulin Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 6
• XXE5XN6 Measurement of Infection, Positive Blood Culture Fluorescence Hybridization for Organism Identification, Concentration and Susceptibility, New Technology Group 6
• XXEBXQ6 Measurement of Infection, Lower Respiratory Fluid Nucleic Acid-base Microbial Detection, New Technology Group 6